TY  - GEN
AU  - Sato,Mototaka
AU  - Nakai,Yasutomo
AU  - Nakata,Wataru
AU  - Yoshida,Takahiro
AU  - Hatano,Koji
AU  - Kawashima,Atsunari
AU  - Fujita,Kazutoshi
AU  - Uemura,Motohide
AU  - Takayama,Hitoshi
AU  - Nonomura,Norio
TI  - EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome
SN  - 1932-6203
PY  - 2014///0527
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Apoptosis
KW  - Basigin
KW  - physiology
KW  - Blotting, Western
KW  - Carcinoma, Renal Cell
KW  - blood supply
KW  - Cell Movement
KW  - Cell Proliferation
KW  - Down-Regulation
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Indoles
KW  - pharmacology
KW  - Kidney
KW  - drug effects
KW  - Kidney Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Neoplasm Staging
KW  - Neovascularization, Pathologic
KW  - metabolism
KW  - Pyrroles
KW  - RNA, Messenger
KW  - genetics
KW  - RNA, Small Interfering
KW  - Real-Time Polymerase Chain Reaction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Sunitinib
KW  - Tumor Cells, Cultured
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0074313
ER  -